Global Market for Contract Research Organization (CRO) Services

Jan 2022| PHM186B| BCC Publishing
Sample Report

Report Highlights

The global market for CRO services should grow from $54.6 billion in 2021 to $83.6 billion by 2026, at compound annual growth rate (CAGR) of 8.9% for the period of 2021-2026.

Report Includes

  • 35 tables
  • An updated review of the global markets for in vitro toxicity testing and technologies under development
  • Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market for in vitro toxicity testing over the next five years (2021 to 2026)
  • Evaluation and forecast the overall market size, and corresponding market share analysis by testing method, component, application, technology, end-user industry, and geographic region
  • Highlights of the impact of COVID-19 on the progress of this market
  • Review of key technology developments, latest market trends, and other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics, and chemicals
  • Insight into recent industry structure, current competitive scenario, R&D activities, and regulatory and legislative issues currently focused on in vitro toxicology
  • Descriptive company profiles of the leading market players including Charles River Laboratories, Evotec, Frontage Labs, ICON PLC, Medpace, PPD Inc., and Syneos Health

Report Scope

The Global CRO market is identified in this report, along with all major global CRO companies. The total CRO market is broken out globally and by geographic region. All major therapeutic areas covered by CROs in the clinical trial process are detailed. The service areas provided by CROs are extensively covered, as well. The phases of the clinical trial process and the role provided by CROs are detailed in this report, as well. The current report will provide detailed examination of CRO services, analyzing market trends for CRO services with data from 2020, estimates from 2021 and projections of CAGR through 2026 (forecast period 2021-2026).

This report provides detailed analysis of the top CROs and evolving roles in the clinical trial process. Faced with the rapid development of new therapies, pharmaceutical companies increasingly turn to CROs. CRO expertise within specific therapeutic areas and experience with new and adaptive study design protocols, can reduce costs and study duration. With typical clinical trials costing nearly $2.5 billion and spanning over a decade, from initial testing to Phase IV and post market approval, a thriving market exists to lower these costs and timelines. CROs are expected to continue to play an increasing role in many facets of the clinical trial process. Oncology, neurology, cardiovascular, metabolism-diabetes, vaccines and other rapidly growing therapeutic areas that have a significant number of drugs in the clinical trial process are detailed in this report.

Strong demand for CROs leads to heightened market valuations and to a plethora of blockbuster mergers and acquisitions (M&As). M&As led to a few powerful companies with expertise across many areas of the clinical trial process. Niche players are still playing a critical role. Emerging trends and changing dynamics within the CRO industry are analyzed, in detail, in this report.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Global Market for Contract Research Organization (CRO) Services109 $5,500 Free
Chapter- 1: Introduction8Free DownloadFree
Chapter- 2: Summary and Highlights6$250Free
Chapter- 3: Market Dynamics4$204Free
Chapter- 4: Impact of COVID-193$153Free
Chapter- 5: Overview: Clinical Trial Process and CRO Functional Services17$866Free
Chapter- 6: Global Market Overview10$509Free
Chapter- 7: Emerging Trends10$509Free
Chapter- 8: Market Breakdown by Region11$560Free
Chapter- 9: Competitive Landscape11$560Free
Chapter- 10: Mergers and Acquisitions6$306Free
Chapter- 11: Company Profiles22$1,120Free
Chapter- 12: Appendix: Abbreviations and Acronyms1$51Free
Published - Dec-2018| Analyst - David Christofides| Code - PHM186A

Report Highlights

The global market for CRO's across the clinical trial process should grow from $45.5 billion in 2017 to reach $72.3 billion by 2022 at a compound annual growth rate (CAGR) of 9.7% for the period of 2017-2022.

Report Includes

  • 19 tables
  • An overview of the global market for contract research organization (CRO) services
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Analyses of the CRO market by services, trial phases, and geographical region
  • Coverage of all major therapeutic areas covered by CROs in the clinical trial process and the types of services they provide
  • Examination of competitive landscape of the market, including mergers and acquisitions, and current pharma CRO contracts
  • Company profiles of key market players, including Charles River Laboratories, Icon Plc, Parexel, Pharmaceutical Product Development and Quintiles
Global Market for Contract Research Organization (CRO) Services

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.